The novel therapy of this peptide represents a major development in the care of diabetes mellitus type 2. Unlike existing therapies, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatidepeptide045747.dailyhitblog.com/47739792/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment